A patient in her Early 40s with New #Raynaud for 6 months. Look at that #ANA, and see right below it (something I missed at 1st glance)… important not to ignore that! This is her #Capillaroscopy What will you do?

Prevalence of subclinical GCA in newly diagnosed PMR #EULAR22

The mechanism underlying #Sjögren syndrome is the destruction of the epithelium of the exocrine glands go.nature.com/29qa0zU #WorldSjögrensDay #SjS

Comparison of American College of Rheumatology/Vasculitis Foundation Guideline(ACR/VF 2021) and European Alliance of Associations of Rheumatology(EULAR2022) Recommendations for Management of ANCA Vasculitis #MedTwitter #RheumTwitter #NephTwitter #Pulmtwitter #MedEd #FOAMed

Diagnosis and management of hypocomplementemic urticarial vasculitis #vasculitis #urticarial #HUV #FVSG #GFEV

Diagnosis of cryoglobulinemia vasculitis - French Vasculitis Study Group #vasculitis #cryoglobulin #FVSG #GFEV

Diagnosis and management of polyarteritis nodosa - French Vasculitis Study Group #vasculitis #PAN #FVSG #GFEV

Connective tissue disease-associated interstitial lung disease - By Florence Delestre (Fellow in Internal Medicine, Paris, France) #ILD #autoimmunedisease #CTD #InternistAcademy

"The distance between dreams and reality is called discipline." | Paulo Coelho

Interesting talk about Neuropsiquiatric Lupus by Prof. Diamond. Brain-reactive autoantibodies #LUPUS2022 SLEuro

New content online! Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases dlvr.it/SZdV05

They are finally out! 2022 ACR/EULAR Classification Criteria for Giant Cell Arteritis and Takayasu's Arteritis!!!! onlinelibrary.wiley.com/doi/10.1002/ar… onlinelibrary.wiley.com/doi/10.1002/ar…

✨ Check out our new #RheumMadness x Rheum OnePagers Bracket Infographic! 🏀📟 📖 Review Most Pivotal Studies in Rheum 🖥️ Read Scouting Reports Online 🏀 *1 Week Left to Submit Bracket* 📆 Bracket Due: Wed, Mar 22 at 11:59pm EST Thank you #RheumMadness Team & @DavidLeverenz!

NEW RESEARCH—What is the optimal dose of #methotrexate to administer with a TNF inhibitor? The MIRACLE trial shows that adalimumab + reduced-dose methotrexate is non-inferior to adalimumab + maximal-dose methotrexate in patients with #rheumatoidarthritis thelancet.com/journals/lanrh…

2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria In Arthritis & Rheumatology loom.ly/3GI96GQ jointly supported by @acr_rheum and EULAR

Blistering editorial from Richard Conway, highlighting some of the peculiar recommendations from the recent American College of Rheumatology RA-ILD guidelines Thoroughly enjoyed this; only critique is that he ended too soon, left lots of meat on the bone rheumnow.com/news/new-acr-r…

✅ Let's review the full list of the NEW #EULAR recommendations 🧑‍🎓 for #LUPUS. Today, let's have a look 🔎 at the 13 main statements 👍 According to YOU what is the most important 💪 advance? Which one(s) are maybe weaker?

✅ Today, let's check the first 😏#2023 EULAR guideline for #Lupus #nephritis (statement 8) For active proliferative #LN: ➡️ IV-mPred + oral GCs ➡️ MMF or ld IV CYC (Eurolupus) ➡️ Belimumab or CNI should be considered Question to our #nephrology colleagues: what do you think?

#VEXAS is associated with atypical infections. Our study is now available in @ARD_BMJ. Thanks again to Marion Delaune Benjamin Valence Jerome HADJADJ @YannNgyn and all the FRENVEX. ard.bmj.com/content/early/…

New content online! Advances in the treatment of polymyalgia rheumatica and giant cell arteritis dlvr.it/T16wWm